Biography
Dr. Finny Monickaraj Swamidoss studies how inflammation and metabolic stress drive vascular damage and fibrosis in diabetic retinopathy. His research integrates molecular biology, multi-omics profiling, and organ-on-a-chip disease modeling to identify new therapeutic targets that protect retinal health. He is particularly interested in the role of neutrophil extracellular traps (NETs) and immune-mediated signaling in retinal vascular dysfunction and scarring.
Dr. Swamidoss’s long-term goal is to translate mechanistic discoveries into novel, mechanism-based therapies to prevent vision loss in patients with diabetes.
Personal Statement
My research aims to elucidate the mechanisms by which chronic inflammation and immune dysregulation in diabetes contribute to retinal injury and fibrosis. By combining modern molecular tools with translational models, my goal is to discover new therapeutic strategies that restore vascular balance and protect vision in diabetic patients.
Areas of Specialty
Diabetic retinopathy and retinal fibrosis
Neutrophil biology and inflammation
Vascular permeability and microvascular dysfunction
Drug repurposing and therapeutic screening
Organ-on-a-chip disease modeling
Education
PhD in Biochemistry, University of Madras, India
Postdoctoral Training, University of New Mexico Health Sciences Center
Gender
Male